Wbh Advisory Inc Abb Vie Inc. Transaction History

Wbh Advisory Inc

$1.05 Billion
Q3 2024

A detailed history of Wbh Advisory Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Wbh Advisory Inc holds 7,259 shares of ABBV stock, worth $1.29 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

7,259

Previous 7,309 0.68%

Holding current value

$1.29 Million

Previous $1.25 Million 14.37%

% of portfolio

0.14%

Previous 0.13%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $8,192 - $9,966	-50 Reduced 0.68%	7,259 $1.43 Million
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $3,714 - $4,338	-24 Reduced 0.33%	7,309 $1.25 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $4,155 - $4,734	-26 Reduced 0.35%	7,333 $1.34 Million
Q4 2023 Jan 09, 2024	SELL	$137.6 - $154.97 $12,521 - $14,102	-91 Reduced 1.22%	7,359 $1.14 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $5,877 - $6,804	-44 Reduced 0.59%	7,450 $1.11 Million
Q2 2023 Jul 12, 2023	SELL	$132.51 - $164.9 $13,251 - $16,490	-100 Reduced 1.32%	7,494 $1.01 Million
Q1 2023 Apr 20, 2023	SELL	$144.61 - $166.54 $365,284 - $420,680	-2,526 Reduced 24.96%	7,594 $1.21 Million
Q3 2022 Oct 18, 2022	SELL	$134.21 - $153.93 $671 - $769	-5 Reduced 0.05%	10,120 $1.36 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $97,797 - $121,338	-741 Reduced 6.82%	10,125 $1.64 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $39,534 - $50,022	368 Added 3.51%	10,866 $1.47 Million
Q2 2021 Jul 27, 2021	SELL	$105.21 - $117.21 $26,407 - $29,419	-251 Reduced 2.34%	10,498 $1.24 Million
Q1 2021 Apr 19, 2021	SELL	$102.3 - $112.62 $16,879 - $18,582	-165 Reduced 1.51%	10,749 $1.16 Million
Q4 2020 Jan 21, 2021	SELL	$80.49 - $108.67 $4,024 - $5,433	-50 Reduced 0.46%	10,914 $1.23 Million
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $20,188 - $23,695	-235 Reduced 2.1%	10,964 $960,000
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $14,747 - $19,734	201 Added 1.83%	11,199 $1.1 Million
Q1 2020 May 07, 2020	SELL	$64.5 - $97.79 $40,054 - $60,727	-621 Reduced 5.34%	10,998 $837,000
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $6,419 - $8,032	-89 Reduced 0.76%	11,619 $1.03 Million
Q3 2019 Oct 25, 2019	SELL	$62.98 - $75.72 $87,794 - $105,553	-1,394 Reduced 10.64%	11,708 $886,000
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $3,942 - $5,038	60 Added 0.46%	13,102 $952,000
Q1 2019 Apr 22, 2019	BUY	$77.14 - $90.79 $539 - $635	7 Added 0.05%	13,042 $1.05 Million
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $3,581 - $4,416	-46 Reduced 0.35%	13,035 $1.2 Million
Q3 2018 Oct 29, 2018	SELL	$88.91 - $98.84 $159,504 - $177,318	-1,794 Reduced 12.06%	13,081 $1.24 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $38,605 - $45,678	-430 Reduced 2.81%	14,875 $1.38 Million
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $11,133 - $14,908	-121 Reduced 0.78%	15,305 $1.45 Million
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $18,270 - $20,034	204 Added 1.34%	15,426 $1.49 Million
Q3 2017 Nov 29, 2017	BUY	$69.85 - $89.22 $1.06 Million - $1.36 Million	15,222	15,222 $1.35 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbh Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wbh Advisory Inc with notifications on news.

Account